Fundraising FoxCreasallis
4 known investors
Find your way into Creasallis
Sign up to see every warm intro you have to Creasallis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Creasallis team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Creasallis develops CreaTap, a patented "plug-and-play" antibody modification technology that improves the penetration of antibody-based drugs into solid tumours, applicable to monoclonal, bispecific, and antibody-drug conjugates. It serves biopharmaceutical companies developing oncology therapeutics and is also building its own suite of antibody therapeutics with enhanced tumour penetration.
Founders & leadership
Investors · 4
How we know: BlueYard Capital's portfolio page · funding news · press coverage · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Creasallis do?
- Creasallis develops CreaTap, a patented "plug-and-play" antibody modification technology that improves the penetration of antibody-based drugs into solid tumours, applicable to monoclonal, bispecific, and antibody-drug conjugates. It serves biopharmaceutical companies developing oncology therapeutics and is also building its own suite of antibody therapeutics with enhanced tumour penetration.
- Who founded Creasallis?
- Creasallis was founded by Zahra Jawad.
- Who are Creasallis's investors?
- Creasallis's investors include BlueYard Capital, Pace Ventures, ZAKA VC, KdT Ventures.